{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-019775","form_type":"8-K","ticker":"MBOT","cik":"0000883975","company_name":"Microbot Medical Inc.","filed_at":"2026-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.865116+00:00","generated_at":"2026-05-15T01:24:48.357702+00:00","sec_items":["7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.45,"confidence":"high","headline":"Microbot Medical appoints Alon Tamir VP Sales EMEA, targets CE mark by end of 2026","bullets":["Alon Tamir named Vice President of Sales for Europe, Middle East and Asia (EMEA) to lead international expansion.","Company expects CE mark approval by end of 2026; leveraging FDA clearance received September 2025.","Europe has approximately 2.3 million peripheral endovascular procedures annually, comparable to U.S. market size.","LIBERTY Endovascular Robotic System is in full market release in the U.S. after limited market release."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-019775","json":"https://secwatch.observer/filing/0001493152-26-019775.json","markdown":"https://secwatch.observer/filing/0001493152-26-019775.md","text":"https://secwatch.observer/filing/0001493152-26-019775.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883975/000149315226019775/0001493152-26-019775-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883975/000149315226019775/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T01:24:48.357702+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}